Commonwealth Equity Services’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.29M | Sell |
12,131
-756
| -6% | -$132K | ﹤0.01% | 1891 |
|
|
2025
Q4 | $2.19M | Buy |
12,887
+769
| +6% | +$118K | ﹤0.01% | 1892 |
|
|
2025
Q3 | $1.6M | Buy |
12,118
+810
| +7% | +$97.2K | ﹤0.01% | 2201 |
|
|
2025
Q2 | $1.2M | Sell |
11,308
-2,899
| -20% | -$315K | ﹤0.01% | 2415 |
|
|
2025
Q1 | $1.76M | Buy |
14,207
+1,323
| +10% | +$173K | ﹤0.01% | 1998 |
|
|
2024
Q4 | $1.59M | Sell |
12,884
-784
| -6% | -$92.4K | ﹤0.01% | 2036 |
|
|
2024
Q3 | $1.52M | Buy |
13,668
+146
| +1% | +$16K | ﹤0.01% | 2022 |
|
|
2024
Q2 | $1.44M | Buy |
13,522
+364
| +3% | +$40K | ﹤0.01% | 2005 |
|
|
2024
Q1 | $1.58M | Buy |
13,158
+2,318
| +21% | +$284K | ﹤0.01% | 1927 |
|
|
2023
Q4 | $1.33M | Buy |
10,840
+767
| +8% | +$95.7K | ﹤0.01% | 1969 |
|
|
2023
Q3 | $1.3M | Buy |
10,073
+962
| +11% | +$128K | ﹤0.01% | 1891 |
|
|
2023
Q2 | $1.13M | Buy |
9,111
+47
| +0.5% | +$6.32K | ﹤0.01% | 2008 |
|
|
2023
Q1 | $1.33K | Sell |
9,064
-300
| -3% | -$44.4K | ﹤0.01% | 1847 |
|
|
2022
Q4 | $1.49M | Sell |
9,364
-96
| -1% | -$14.1K | ﹤0.01% | 1688 |
|
|
2022
Q3 | $1.26M | Sell |
9,460
-30
| -0.3% | -$4.56K | ﹤0.01% | 1740 |
|
|
2022
Q2 | $1.48M | Sell |
9,490
-677
| -7% | -$104K | ﹤0.01% | 1608 |
|
|
2022
Q1 | $1.58M | Buy |
10,167
+447
| +5% | +$64.9K | ﹤0.01% | 1647 |
|
|
2021
Q4 | $1.24M | Sell |
9,720
-10,475
| -52% | -$1.38M | ﹤0.01% | 1832 |
|
|
2021
Q3 | $2.63M | Buy |
20,195
+8,672
| +75% | +$1.31M | 0.01% | 1265 |
|
|
2021
Q2 | $2.05M | Buy |
11,523
+7,397
| +179% | +$1.28M | 0.01% | 1407 |
|
|
2021
Q1 | $678K | Sell |
4,126
-10,523
| -72% | -$1.73M | ﹤0.01% | 2082 |
|
|
2020
Q4 | $2.42M | Buy |
14,649
+11,559
| +374% | +$1.72M | 0.01% | 1118 |
|
|
2020
Q3 | $440K | Sell |
3,090
-354
| -10% | -$43.9K | ﹤0.01% | 2058 |
|
|
2020
Q2 | $380K | Sell |
3,444
-920
| -21% | -$102K | ﹤0.01% | 2091 |
|
|
2020
Q1 | $435K | Buy |
4,364
+437
| +11% | +$56.5K | ﹤0.01% | 1789 |
|
|
2019
Q4 | $586K | Buy |
3,927
+816
| +26% | +$111K | ﹤0.01% | 1782 |
|
|
2019
Q3 | $398K | Sell |
3,111
-227
| -7% | -$30.4K | ﹤0.01% | 2001 |
|
|
2019
Q2 | $475K | Buy |
3,338
+92
| +3% | +$12.4K | ﹤0.01% | 1842 |
|
|
2019
Q1 | $464K | Buy |
3,246
+290
| +10% | +$37.8K | ﹤0.01% | 1800 |
|
|
2018
Q4 | $366K | Sell |
2,956
-244
| -8% | -$36.2K | ﹤0.01% | 1868 |
|
|
2018
Q3 | $538K | Sell |
3,200
-309
| -9% | -$53.1K | ﹤0.01% | 1749 |
|
|
2018
Q2 | $605K | Buy |
3,509
+226
| +7% | +$36.9K | ﹤0.01% | 1618 |
|
|
2018
Q1 | $495K | Sell |
3,283
-113
| -3% | -$16.6K | ﹤0.01% | 1720 |
|
|
2017
Q4 | $457K | Sell |
3,396
-723
| -18% | -$100K | ﹤0.01% | 1752 |
|
|
2017
Q3 | $602K | Sell |
4,119
-25
| -0.6% | -$3.78K | ﹤0.01% | 1494 |
|
|
2017
Q2 | $644K | Sell |
4,144
-1,500
| -27% | -$229K | ﹤0.01% | 1402 |
|
|
2017
Q1 | $819K | Sell |
5,644
-662
| -10% | -$86.2K | 0.01% | 1223 |
|
|
2016
Q4 | $688K | Buy |
6,306
+358
| +6% | +$39.9K | 0.01% | 1231 |
|
|
2016
Q3 | $723K | Buy |
5,948
+267
| +5% | +$36K | 0.01% | 1167 |
|
|
2016
Q2 | $803K | Buy |
5,681
+230
| +4% | +$33.9K | 0.01% | 1094 |
|
|
2016
Q1 | $712K | Sell |
5,451
-92
| -2% | -$11.5K | 0.01% | 1122 |
|
|
2015
Q4 | $779K | Buy |
5,543
+330
| +6% | +$45.7K | 0.01% | 1057 |
|
|
2015
Q3 | $692K | Buy |
5,213
+712
| +16% | +$123K | 0.01% | 1074 |
|
|
2015
Q2 | $792K | Sell |
4,501
-120
| -3% | -$21.6K | 0.01% | 1084 |
|
|
2015
Q1 | $798K | Sell |
4,621
-279
| -6% | -$47.9K | 0.01% | 1071 |
|
|
2014
Q4 | $802K | Buy |
4,900
+686
| +16% | +$114K | 0.01% | 1012 |
|
|
2014
Q3 | $677K | Buy |
4,214
+770
| +22% | +$118K | 0.01% | 1064 |
|
|
2014
Q2 | $506K | Sell |
3,444
-1,405
| -29% | -$195K | 0.01% | 1235 |
|
|
2014
Q1 | $672K | Sell |
4,849
-2,282
| -32% | -$343K | 0.01% | 1026 |
|
|
2013
Q4 | $902K | Sell |
7,131
-207
| -3% | -$21.4K | 0.01% | 822 |
|
|
2013
Q3 | $675K | Buy |
7,338
+190
| +3% | +$15.3K | 0.01% | 924 |
|
|
2013
Q2 | $491K | Buy |
+7,148
| New | +$437K | 0.01% | 1031 |
|
Other funds holding JAZZ
VPM
VCM
EC
Commonwealth Equity Services's JAZZ Position: Q1 2026 in Review
Commonwealth Equity Services reduced its Jazz Pharmaceuticals (JAZZ) stake by 5.9% in Q1 2026, selling an estimated $132K and leaving 12,131 shares worth $2.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1891.
Commonwealth Equity Services first reported a position in JAZZ in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.63M in Q3 2021. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Commonwealth Equity Services held 12,131 shares of Jazz Pharmaceuticals worth $2.29M as of Q1 2026.
- Commonwealth Equity Services sold 756 Jazz Pharmaceuticals shares in Q1 2026, an estimated $132K.
- Jazz Pharmaceuticals made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #1891 holding.
- Commonwealth Equity Services first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Commonwealth Equity Services's Jazz Pharmaceuticals position peaked at $2.63M in Q3 2021.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.